Patent · US Expired

Double brilliance beta-arrestin: a biosensor for monitoring the activity of receptors and signalling molecules, and method of using same

US7932080B2 · kind B2 · utility

1Cited by
0References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 4, 2005
Grant dateApr 26, 2011
Priority date
Expiry dateApr 13, 2026

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/726
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

An intramolecular bioluminescence resonance energy transfer (BRET), biosensor for monitoring receptor activity and signalling cascades is disclosed. The “double-brilliance” biosensor sandwiches β-arrestin (β-arr) between Renilla luciferase (Luc) and the yellow fluorescent protein (YFP). β-arr associates with G-protein coupled receptors GPCR following receptor activation, bringing Luc and YPF into close proximity that favours energy transfer. In addition to providing new insights into the agonist-induced conformational rearrangements of β-arr in living cells, the double-brilliance β-arr offers a universal biosensor for GPCR activation, allowing the study of native receptors in large-scale screening analysis. The activity of other signalling molecules known to interact with β arrestin could also be monitored by double brilliance β arr.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.